BNTX vs REGN: Which Stock is Better?
Side-by-side comparison of Biontech Se and Regeneron Pharmaceuticals Inc in 2026
BNTX
Biontech Se
$100.76
REGN
Regeneron Pharmaceuticals Inc
$766.66
Key Metrics Comparison
| Metric | BNTX | REGN | Winner |
|---|---|---|---|
| Market Cap | $26.97B | $83.60B | REGN |
| P/E Ratio | N/A | 19.05 | REGN |
| EPS (TTM) | $N/A | $41.52 | REGN |
| Revenue Growth | 0.2% | 0.0% | BNTX |
| Gross Margin | 82.5% | 44.6% | BNTX |
Analyze BNTX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BNTX or REGN a better investment?
Comparing BNTX and REGN: Biontech Se has a market cap of $26.97B while Regeneron Pharmaceuticals Inc has $83.60B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BNTX and REGN?
BNTX (Biontech Se) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BNTX or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: BNTX or REGN?
BNTX has higher revenue growth at 0.2% vs 0.0% for REGN.
Which company is more profitable: BNTX or REGN?
Biontech Se (BNTX) has higher gross margins at 82.5% compared to 44.6% for REGN.
Which is the larger company: BNTX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $83.60B compared to $26.97B for BNTX.
Should I buy BNTX or REGN in 2026?
Both BNTX and REGN have investment merit. BNTX trades at $100.76 while REGN trades at $766.66. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BNTX and REGN stock?
Key differences: Market Cap ($26.97B vs $83.60B), P/E Ratio (N/A vs 19.0x), Revenue Growth (0.2% vs 0.0%), Gross Margin (82.5% vs 44.6%).